Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacological Postconditioning with Exenatide in STEMI
NCT00835848Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Jan 2009
- Primary completion
- Dec 2009
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide in ST elevation myocardial infarction (STEMI), sponsored by Rigshospitalet. Started Jan 2009; status: completed.
02
Drugs
exenatide
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT00835848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00835848.